Microbot Medical Inc.
MBOT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $17,522 | $16,728 | $21,853 | $53,310 |
| - Cash | $3,114 | $2,468 | $2,442 | $13,493 |
| + Debt | $111 | $231 | $462 | $680 |
| Enterprise Value | $14,519 | $14,491 | $19,873 | $40,497 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$91 | -$106 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$11,352 | -$10,634 | -$13,335 | -$11,281 |
| % Margin | – | – | – | – |
| Net Income | -$11,443 | -$10,740 | -$13,168 | -$11,313 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.73 | -1.05 | -1.81 | -1.59 |
| % Growth | 30.5% | 42% | -13.8% | – |
| Operating Cash Flow | -$8,827 | -$8,533 | -$11,549 | -$9,354 |
| Capital Expenditures | -$25 | -$33 | -$84 | -$69 |
| Free Cash Flow | -$8,852 | -$8,566 | -$11,633 | -$9,423 |